Ventas (NYSE:VTR) announces that the Ventas Life Science and Healthcare Real Estate Fund has acquired a trophy life science portfolio in the premier South San Francisco life science cluster for $1B.
The portfolio consists of a campus of three newly developed or renovated buildings totaling nearly 800,000 square feet.
Ventas now owns or has investments in a research & innovation portfolio containing 7.3M square feet and spanning 39 operating properties.
The company is expanding with four new properties, consisting of 1.5M additional square feet, currently under development with three leading research institutions.
